Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984:6:271-4.

Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow

Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow

T C Stephens et al. Br J Cancer Suppl. 1984.

Abstract

In vivo ultra low dose rate continuous irradiation (CI, 15 cGy h-1) was used in an attempt to accurately quantify low dose radiation response (less than 2 Gy) of both tumour and normal tissue, a parameter which is clinically relevant but difficult to assess using conventional acute radiation survival curves. Dorsally placed tumours were irradiated by housing tumour bearing mice for up to three weeks in a dedicated 137Cs unit taking care to shield the lower body. Response to CI was monitored by an excision cell survival assay. For bone marrow treatment whole body irradiation was used and BM-CFUc were assessed. In all 4 tissues studied (Lewis lung carcinoma, B16 melanoma, carcinoma MT and C57B1/6 bone marrow) cell survival decreased exponentially with dose; the three tumours had similar D0 (approximately 6 Gy), bone marrow was more sensitive (D0 1.5 Gy). Acute in vitro radiation survival curves were analysed using both the multi-target plus single hit and the linear quadratic models of radiation cell kill. Comparison of CI results with acute radiation survival curve parameters derived from each model suggest that CI offers a useful means of assessing the low dose radiosensitivity of tumours and may therefore be useful in the prediction of tumour response to clinically relevant fractionated treatments.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Phys Med Biol. 1973 Jan;18(1):78-87 - PubMed
    1. Radiat Res. 1983 Apr;94(1):105-34 - PubMed
    1. Br J Radiol. 1980 Dec;53(636):1182-7 - PubMed
    1. Int J Radiat Biol Relat Stud Phys Chem Med. 1978 Jun;33(6):599-603 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1981 May;7(5):621-9 - PubMed

LinkOut - more resources